Although is not entirely approved in the us, there is a regimen in use in
europe for patients who have failed 5fu,leucovorin for met colon cancer.
Contact dr jerome landry at 404-616-3948 for more information.At 07:25 PM
3/10/98 -0800, you wrote:
>Husband Joe was diagnosed in October, 97 with colon cancer with mets to
>the liver, stage IV. No clue before he went for his physical and had a
>low hematocrit. He has undergone nine treatments of 5FU/leukovorin.
>The CATscan taken in Feb. shows an increase in the tumors. He started
>taking shark cartilage 3000mgm/day three weeks ago. He is desperate,
>depressed, searching and willing to volunteer for anything. He was also
>told that he doesn't qualify for clinical trials due to the fact that he
>has already undergone chemo. I have been reading about thalidomide and
>hearing about it on TV. Is it available or under testing? Has it been
>approved by the FDA? Is there anywhere Joe can go to try it?
>Thank you,
>
>Mary Lou
>------------------------------------------------------------------------
>This is an automatically-generated notice. If you'd like to be removed
>from the mailing list, please visit the Medicine-On-Line Discussion Forum
>at <http://www.meds.com/con_faq.html>, or send an email message to:
>majordomo@lists.meds.com
>with the subject line blank and the body of the message containing the line:
>unsubscribe mol-cancer your-email-address
>where the phrase your-email-address is replaced with your actual email
>address.
>------------------------------------------------------------------------
>
>
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
